Neuro Athletics is a 3x weekly newsletter that breaks down the medical and scientific practises that you need to perform at your peak. Subscribers include professional athletes, athletic trainers, coaches and casual fans. So if you are not already a subscriber, sign up and join 65,000+ others who receive it directly in their inbox each week — it’s free.

Today At A Glance:

Dr. Charles Brenner and Dr. David Sinclair hold opposing views on longevity research, with Brenner focusing on NAD+ metabolism and Sinclair championing sirtuins as longevity genes. Brenner criticizes Sinclair's work as "massively overinterpreted," especially when applied to human aging. Publication bias, favoring positive over negative results, further complicates the field. These disagreements underscore the need for unbiased, rigorous research on aging.

Neuro Athletes,

In the quest to understand the aging process and how to slow it down, the world of longevity research is anything but straightforward. Scientists have long been exploring a variety of pathways that may influence lifespan, cellular health, and overall well-being. Two prominent figures in the longevity research space, Dr. Charles Brenner and Dr. David Sinclair, offer contrasting views on some key aspects of aging, such as the role of NAD and sirtuins.

The Role of NAD

Dr. Charles Brenner, an expert in the field, argues that while Nicotinamide Adenine Dinucleotide (NAD) is important for cellular health, its role in extending lifespan remains unconfirmed. According to Brenner, it's crucial to differentiate between evidence-based science and over-interpretation. He emphasizes a balanced lifestyle that includes exercise and good nutrition as a more reliable approach to healthy aging.

The Sirtuin Saga

On the flip side, Dr. David Sinclair's research centers around the concept of sirtuins, which he argues are longevity genes. Sinclair’s work, in collaboration with other researchers, initially found that a gene called "sirtuin" controlled the aging process in yeast cells. However, according to Brenner, these findings have been "massively overinterpreted."

The Controversy

The discord between the two experts extends to the realm of publishing. Dr. Brenner points out that there's a bias towards publishing "exciting positive results," which can hinder the communication of negative data that may actually be more accurate. According to him, the publication of negative results has been obstructed due to commercial and reputational interests, which further complicates the aging narrative.

Dr. Brenner specifically cites a 1997 paper by Sinclair that has been validated but also argues it has been "massively overinterpreted." Sinclair believes that sirtuins could have implications for human aging, but Brenner counters this, stating that the early findings were not as broadly applicable as they have been made out to be. Brenner even questions the efficacy of compounds like Resveratrol, often touted as sirtuin activators, citing unconvincing human data and commercial interests.

Reputational Interests and The Road Ahead

Brenner also discusses the difficulties in publishing research that contradicts established narratives, particularly when those narratives are deeply tied to commercial interests. In the world of sirtuins, for example, a biotech company called Sirtris sold for $720 million based on the promise of sirtuins as a drug target. This, despite a lack of consensus in the scientific community and even published negative results questioning the longevity-enhancing role of sirtuins.

My Thoughts

So, where does this leave us? While Brenner stresses a balanced approach towards lifestyle and questions the role of sirtuins and NAD in aging, Sinclair continues to defend the idea of sirtuins as longevity genes. Whether it’s a balanced diet and exercise, or a breakthrough in sirtuin science, the jury is still out on the definitive way to extend human life.

As the field of longevity science continues to evolve, it is essential to scrutinize the data rigorously and engage in open dialogues, like the one we wish to see between Dr. Brenner and Dr. Sinclair. After all, the stakes are nothing less than understanding the mysteries of aging itself.

Listen to the episode here.

You can listen to this on Apple iTunes also.